Does FOSCARBIDOPA\FOSLEVODOPA Cause Gait inability? 52 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Gait inability have been filed in association with FOSCARBIDOPA\FOSLEVODOPA. This represents 1.7% of all adverse event reports for FOSCARBIDOPA\FOSLEVODOPA.
52
Reports of Gait inability with FOSCARBIDOPA\FOSLEVODOPA
1.7%
of all FOSCARBIDOPA\FOSLEVODOPA reports
3
Deaths
37
Hospitalizations
How Dangerous Is Gait inability From FOSCARBIDOPA\FOSLEVODOPA?
Of the 52 reports, 3 (5.8%) resulted in death, 37 (71.2%) required hospitalization, and 1 (1.9%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSCARBIDOPA\FOSLEVODOPA. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does FOSCARBIDOPA\FOSLEVODOPA Cause?
On and off phenomenon (391)
Fall (343)
Hallucination (293)
Dyskinesia (237)
Death (203)
General physical health deterioration (173)
Infusion site erythema (157)
Mobility decreased (154)
Infusion site pain (143)
Malaise (139)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which FOSCARBIDOPA\FOSLEVODOPA Alternatives Have Lower Gait inability Risk?
FOSCARBIDOPA\FOSLEVODOPA vs FOSCARNET
FOSCARBIDOPA\FOSLEVODOPA vs FOSFOMYCIN
FOSCARBIDOPA\FOSLEVODOPA vs FOSFOMYCIN TROMETHAMINE
FOSCARBIDOPA\FOSLEVODOPA vs FOSINOPRIL
FOSCARBIDOPA\FOSLEVODOPA vs FOSPHENYTOIN